HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML

NCT06594445 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Malignancy
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: GTB-360

Sponsor

Masonic Cancer Center, University of Minnesota